Evrofarma SA
Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.
Evrofarma SA (EVROF) - Total Assets
Latest total assets as of December 2022: €48.81 Million EUR
Based on the latest financial reports, Evrofarma SA (EVROF) holds total assets worth €48.81 Million EUR as of December 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Evrofarma SA - Total Assets Trend (2014–2022)
This chart illustrates how Evrofarma SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Evrofarma SA - Asset Composition Analysis
Current Asset Composition (December 2022)
Evrofarma SA's total assets of €48.81 Million consist of 38.3% current assets and 61.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €1.44 Million | 0.0% |
| Accounts Receivable | €11.72 Million | 24.0% |
| Inventory | €5.56 Million | 11.4% |
| Property, Plant & Equipment | €24.15 Million | 49.5% |
| Intangible Assets | €59.00K | 0.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2014–2022)
This chart illustrates how Evrofarma SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Evrofarma SA's current assets represent 38.3% of total assets in 2022, an increase from 29.8% in 2014.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2022, down from 0.2% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is property, plant & equipment at 49.5% of total assets.
Evrofarma SA Competitors by Total Assets
Key competitors of Evrofarma SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
B&G Foods Inc
NYSE:BGS
|
USA | $2.94 Billion |
|
Tangrenshen Group Co Ltd
SHE:002567
|
China | CN¥17.90 Billion |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
China | CN¥7.01 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
Evrofarma SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Evrofarma SA generates 0.93x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Evrofarma SA generates $ 2.91 in net profit.
Evrofarma SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.38 | 1.41 | 1.01 |
| Quick Ratio | 0.84 | 1.03 | 0.80 |
| Cash Ratio | 0.00 | 0.09 | 0.00 |
| Working Capital | €6.57 Million | € 6.57 Million | € 111.00K |
Evrofarma SA - Advanced Valuation Insights
This section examines the relationship between Evrofarma SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.27 |
| Asset Growth Rate (YoY) | 4.9% |
| Total Assets | €48.81 Million |
| Market Capitalization | $13.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values Evrofarma SA's assets below their book value (0.27 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Evrofarma SA's assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Evrofarma SA (2014–2022)
The table below shows the annual total assets of Evrofarma SA from 2014 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | €48.81 Million | +4.93% |
| 2021-12-31 | €46.52 Million | +0.31% |
| 2020-12-31 | €46.38 Million | +12.56% |
| 2019-12-31 | €41.20 Million | -6.85% |
| 2018-12-31 | €44.23 Million | -1.92% |
| 2017-12-31 | €45.09 Million | +3.07% |
| 2016-12-31 | €43.75 Million | -1.34% |
| 2015-12-31 | €44.35 Million | -6.18% |
| 2014-12-31 | €47.27 Million | -- |